Expression of a splice variant of the platelet‐activating factor receptor transcript 2 in various human cancer cell lines
Open Access
- 1 January 2002
- journal article
- Published by Wiley in Mediators of Inflammation
- Vol. 11 (5) , 329-331
Abstract
Platelet‐activating factor receptor (PAF‐R) transcripts were analysed by reverse transcriptase‐polymerase chain reaction in five human cancer cell lines derived from the breast (BT20, SKBR3 and T47D cells), the pancreas (Miapaca cells) and the bladder (5637 cells) in order to confirm the existence of a splice variant of the PAF‐R transcript 2. After cloning and sequencing, we confirmed its existence in all cell lines. It consisted of the PAF‐R transcript 2 lengthening with 82 nucleotides from the 3′ end of exon 1 of the PAF‐R gene. The role of this elongated form of the tissue‐type PAF‐R transcript in cell physiology remains to be elucidated.Keywords
Funding Information
- Corrèze - Ligue contre le cancer
This publication has 5 references indexed in Scilit:
- Metabolism and effect of platelet-activating factor on the growth of human myeloma cell linesCancer Letters, 2000
- Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant miceProgress in Lipid Research, 2000
- Expression of Platelet‐Activating Factor Receptor Transcript‐1 but Not Transcript‐2 by Human Bone Marrow CellsStem Cells, 1999
- Inhibition by Platelet-activating Factor of Src- and Hepatocyte Growth Factor-dependent Invasiveness of Intestinal and Kidney Epithelial CellsJournal of Biological Chemistry, 1998
- Two different promoters direct expression of two distinct forms of mRNAs of human platelet‐activating factor receptorFEBS Letters, 1993